˿Ƶ

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2019 $ 26,461,428 $ 18,666 $ 68,562,727 $ (70,000) $ (42,049,965)
Beginning balance (in shares) at Apr. 30, 2019 18,665,551
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 1,627,304 1,627,304
Common stock issued for cashless stock options exercised 0 $ 191 (191)
Common stock issued for cashless stock options exercised (in shares) 190,559
Common stock issued for stock options exercised for cash 768,381 $ 234 768,147
Common stock issued for stock options exercised for cash (in shares) 234,233
Common stock issued for cashless warrant exercise 0 $ 77 (77)
Common stock issued for cashless warrant exercise (in shares) 76,929
Amortization of warrant based cost 27,690 27,690
Amortization of restricted stock issued for services 97,748 97,748
Restricted stock issued for services, subject to vesting 0 $ 144 (144)
Restricted Stock Issued for Services, subject to vesting (in shares) 144,803
Common stock issued for equity raise, net of underwriter costs 16,044,879 $ 2,415 16,042,464
Common stock issued in equity raise, net of underwriter costs (in shares) 2,415,000
Other offerings costs (51,282) (51,282)
Beneficial conversion feature on convertible debt 1,692,309 1,692,309
Common stock short swing reclamation 5,433 5,433
Net loss (4,994,502) (4,994,502)
Ending balance at Jan. 31, 2020 41,679,388 $ 21,727 88,772,128 (70,000) (47,044,467)
Ending balance (in shares) at Jan. 31, 2020 21,727,075
Beginning balance at Oct. 31, 2019 24,967,090 $ 19,142 69,781,363 (70,000) (44,763,415)
Beginning balance (in shares) at Oct. 31, 2019 19,142,316
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 737,820 737,820
Common stock issued for cashless stock options exercised 0 $ 9 (9)
Common stock issued for cashless stock options exercised (in shares) 8,352
Common stock issued for stock options exercised for cash 530,668 $ 121 530,547
Common stock issued for stock options exercised for cash (in shares) 121,407
Amortization of warrant based cost 9,125 9,125
Amortization of restricted stock issued for services 24,398 24,398
Restricted stock issued for services, subject to vesting 0 $ 40 (40)
Restricted Stock Issued for Services, subject to vesting (in shares) 40,000
Common stock issued for equity raise, net of underwriter costs 16,044,879 $ 2,415 16,042,464
Common stock issued in equity raise, net of underwriter costs (in shares) 2,415,000
Other offerings costs (51,282) (51,282)
Beneficial conversion feature on convertible debt 1,692,309 1,692,309
Common stock short swing reclamation 5,433 5,433
Net loss (2,281,052) (2,281,052)
Ending balance at Jan. 31, 2020 41,679,388 $ 21,727 88,772,128 (70,000) (47,044,467)
Ending balance (in shares) at Jan. 31, 2020 21,727,075
Beginning balance at Apr. 30, 2020 41,747,957 $ 21,771 89,505,216 (70,000) (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020 21,770,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 3,019,828 3,019,828
Common stock issued for cashless stock options exercised 0 $ 22 (22)
Common stock issued for cashless stock options exercised (in shares) 22,339
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601
Common stock issued for conversion of Convertible Notes (in shares) 1,398,602
Common stock issued for stock options exercised for cash 2,578,700 $ 1,365 4,394,749 (1,817,414)
Common stock issued for stock options exercised for cash (in shares) 1,364,721
Common stock issued for vested restricted stock units 0 $ 206 (206)
Common stock issued for vested restricted stock units (in shares) 206,109
Common stock issued for warrants exercised for cash 1,081,792 $ 192 1,081,600
Common stock issued for warrants exercised for cash (in shares) 192,049
Common stock issued for services 19,900 $ 2 19,898
Common stock issued for services (in shares) 2,000
Modification charge for warrants exercised 25,966 25,966
Amortization of warrant based cost 27,375 27,375
Cancellation of treasury stock 0 $ (17) (69,983) 70,000
Cancellation of Treasury Stock (in shares) (16,667)
Net loss (8,128,987) (8,128,987)
Ending balance at Jan. 31, 2021 50,372,531 $ 24,940 108,003,022 (1,817,414) (55,838,017)
Ending balance (in shares) at Jan. 31, 2021 24,939,673
Beginning balance at Oct. 31, 2020 52,094,217 $ 24,417 105,092,551 0 (53,022,751)
Beginning balance (in shares) at Oct. 31, 2020 24,416,539
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 701,170 701,170
Common stock issued for stock options exercised for cash 363,385 $ 447 2,180,352 (1,817,414)
Common stock issued for stock options exercised for cash (in shares) 447,134
Common stock issued for vested restricted stock units 0 $ 74 (74)
Common stock issued for vested restricted stock units (in shares) 74,000
Common stock issued for services 19,900 $ 2 19,898
Common stock issued for services (in shares) 2,000
Amortization of warrant based cost 9,125 9,125
Net loss (2,815,266) (2,815,266)
Ending balance at Jan. 31, 2021 $ 50,372,531 $ 24,940 $ 108,003,022 $ (1,817,414) $ (55,838,017)
Ending balance (in shares) at Jan. 31, 2021 24,939,673